InsidersTradesSigma
Standard Biotools INC.: insider trades · United States · SEC (Form 4)
SEC:standard-biotools-inc-f4549eUS·SEC (Form 4)Mcap 986M€Energy
Discover the full management transaction log of Standard Biotools INC., a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Energy sector, Standard Biotools INC. has published 22 reports. Market capitalisation: €986m. The latest transaction was disclosed on 17 June 2022 (Attribution). Among the most active insiders: Caligan Partners LP. Every trade is free.
22
Insider Decl.
0
Thresholds
€3m
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.88 €
Analyst consensus
Income statement
Net income3.5 M€94.2% margin
Valuation
PER (trailing)20.9x
P/Book0.9x
Balance sheet & cash
Market cap986.0 M€
Free Cash Flow30.6 M€
Profitability & ownership
ROE13.2%
ROA7.9%
% insiders47.4%
% institutions59.4%
Last declaration on 17 June 2022
Declarations22 total
Executives◆Grant12SEC
030,914 shares0
Common Stock
SEC:0001162194-22-000080:0·
Executives▲Purchase23SEC
€163,224100,000 shares@ €1.63220.017% mcap6.0% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-003296:0·
Ideal exit: 10 Mar 2023 (T+270)
Executives▲Purchase25SEC
€357,174200,000 shares@ €1.78590.036% mcap13.1% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-003177:0·
Ideal exit: 27 Feb 2023 (T+270)
Executives◆Grant20SEC
€5,0023,341 shares@ €1.49710.0005% mcap100.0% of flow
Common Stock
SEC:0001162194-22-000065:0·
Executives◇Options12SEC
04,063 shares0
Common Stock
SEC:0001162194-22-000060:0·
Executives◇Options20SEC
02,251 shares0
Common Stock
SEC:0001162194-22-000059:0·
Executives◇Options12SEC
03,125 shares0
Common Stock
SEC:0001162194-22-000061:0·
Executives▲Purchase36SEC
€1m463,350 shares@ €2.75150.13% mcap46.6% of flow
Common Stock, $0.001 par value per share (Common Stock)
SEC:0000902664-22-002849:0·
Ideal exit: 31 Jan 2023 (T+270)
Executives▲Purchase22SEC
€63,06027,600 shares@ €2.28480.0064% mcap2.3% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-002740:0·
Ideal exit: 23 Jan 2023 (T+270)
Executives▲Purchase16SEC
€515,860145,000 shares@ €3.55770.052% mcap18.9% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-002542:0·
Ideal exit: 6 Jan 2023 (T+270)
Executives▲Purchase12SEC
€361,951109,573 shares@ €3.30330.037% mcap13.2% of flow
Common Stock, $0.001 par value per share ("Common Stock")
SEC:0000902664-22-002486:0·
Ideal exit: 1 Jan 2023 (T+270)
Executives◇Options21SEC
€70,91020,993 shares@ €3.37780.0072% mcap82.1% of flow
Common Stock
SEC:0001162194-22-000027:0·
Executives◇Options14SEC
€15,4895,000 shares@ €3.09780.0016% mcap17.9% of flow
Common Stock
SEC:0001162194-22-000025:0·
22 of 22 declarations